Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Menichetti

Showing results (121-130 of 141) with videos related to

Pageof 15
Sort By:
Intensive Care Medicine|October 10, 2013
A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational expertsMatteo Bassetti, Monia Marchetti, Arunaloke Chakrabarti, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 20, 2020
Prolonged outbreak of New Delhi metallo-beta-lactamase-producing carbapenem-resistant Enterobacterales (NDM-CRE), Tuscany, Italy, 2018 to 2019Lara Tavoschi, Silvia Forni, Andrea Porretta, et al.
Infectious Diseases and Therapy|October 2, 2018
Effect and Safety of Meropenem-Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections: The TANGO II Randomized Clinical TrialRichard G Wunderink, Evangelos J Giamarellos-Bourboulis, Galia Rahav, et al.
Open Forum Infectious Diseases|May 29, 2020
Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing <i>Enterobacterales</i> Infections: A Multicenter Nationwide Clinical Experience (CEFTABUSE II Study)Matteo Bassetti, Antonio Vena, Daniele Roberto Giacobbe, et al.
The Journal of Infection|May 31, 2019
Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: Clinical features, therapy and outcome from a multicenter studyAlessandro Russo, Matteo Bassetti, Giancarlo Ceccarelli, et al.
Jac-Antimicrobial Resistance|June 20, 2022
Superinfections caused by carbapenem-resistant Enterobacterales in hospitalized patients with COVID-19: a multicentre observational study from Italy (CREVID Study)Marco Falcone, Lorenzo Roberto Suardi, Giusy Tiseo, et al.
Intensive Care Medicine|March 9, 2017
Clinical characteristics and predictors of mortality in cirrhotic patients with candidemia and intra-abdominal candidiasis: a multicenter studyMatteo Bassetti, Maddalena Peghin, Alessia Carnelutti, et al.
Intensive Care Medicine|June 17, 2015
A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortalityMatteo Bassetti, Elda Righi, Filippo Ansaldi, et al.
Nature|October 1, 2025
Monoclonal antibodies protect against pandrug-resistant Klebsiella pneumoniaeEmanuele Roscioli, Vittoria Zucconi Galli Fonseca, Soraya Soledad Bosch, et al.
Jac-Antimicrobial Resistance|July 8, 2025
Impact of multidrug resistance in cancer patients with bloodstream infections caused by Gram-negative bacilli: results from a multicentre studyMarco Falcone, Sergio Carbonara, Andrea Marino, et al.
Pageof 15

Showing results (121-130 of 141) with videos related to

Sort By:
Pageof 15
Intensive Care Medicine|October 10, 2013
A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational expertsMatteo Bassetti, Monia Marchetti, Arunaloke Chakrabarti, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 20, 2020
Prolonged outbreak of New Delhi metallo-beta-lactamase-producing carbapenem-resistant Enterobacterales (NDM-CRE), Tuscany, Italy, 2018 to 2019Lara Tavoschi, Silvia Forni, Andrea Porretta, et al.
Infectious Diseases and Therapy|October 2, 2018
Effect and Safety of Meropenem-Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections: The TANGO II Randomized Clinical TrialRichard G Wunderink, Evangelos J Giamarellos-Bourboulis, Galia Rahav, et al.
Open Forum Infectious Diseases|May 29, 2020
Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing <i>Enterobacterales</i> Infections: A Multicenter Nationwide Clinical Experience (CEFTABUSE II Study)Matteo Bassetti, Antonio Vena, Daniele Roberto Giacobbe, et al.
The Journal of Infection|May 31, 2019
Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: Clinical features, therapy and outcome from a multicenter studyAlessandro Russo, Matteo Bassetti, Giancarlo Ceccarelli, et al.
Jac-Antimicrobial Resistance|June 20, 2022
Superinfections caused by carbapenem-resistant Enterobacterales in hospitalized patients with COVID-19: a multicentre observational study from Italy (CREVID Study)Marco Falcone, Lorenzo Roberto Suardi, Giusy Tiseo, et al.
Intensive Care Medicine|March 9, 2017
Clinical characteristics and predictors of mortality in cirrhotic patients with candidemia and intra-abdominal candidiasis: a multicenter studyMatteo Bassetti, Maddalena Peghin, Alessia Carnelutti, et al.
Intensive Care Medicine|June 17, 2015
A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortalityMatteo Bassetti, Elda Righi, Filippo Ansaldi, et al.
Nature|October 1, 2025
Monoclonal antibodies protect against pandrug-resistant Klebsiella pneumoniaeEmanuele Roscioli, Vittoria Zucconi Galli Fonseca, Soraya Soledad Bosch, et al.
Jac-Antimicrobial Resistance|July 8, 2025
Impact of multidrug resistance in cancer patients with bloodstream infections caused by Gram-negative bacilli: results from a multicentre studyMarco Falcone, Sergio Carbonara, Andrea Marino, et al.
Pageof 15